Search

Your search keyword '"Vassall A"' showing total 1,438 results

Search Constraints

Start Over You searched for: Author "Vassall A" Remove constraint Author: "Vassall A"
Sorry, I don't understand your search. ×
1,438 results on '"Vassall A"'

Search Results

Catalog

Books, media, physical & digital resources

3. Correction: Effectiveness and cost-effectiveness of a transdiagnostic intervention for alcohol misuse and psychological distress in humanitarian settings: study protocol for a randomised controlled trial in Uganda

4. Effectiveness and cost-effectiveness of a transdiagnostic intervention for alcohol misuse and psychological distress in humanitarian settings: study protocol for a randomised controlled trial in Uganda

5. A Snapshot in Time of COVID-19 Vaccination Hesitancy and Acceptance in Nurses, Nursing Students, and Faculty: Implications for Early Messaging

6. Future support on evidence-informed priority setting and situational analysis of the potential role of Health Technology Assessment in Africa to support future pandemic preparedness and response: protocol for a scoping review

7. Estimating the health and macroeconomic burdens of tuberculosis in India, 2021-2040: A fully integrated modelling study.

8. A health technology assessment of COVID-19 vaccination for Nigerian decision-makers: Identifying stakeholders and pathways to support evidence uptake

9. Cost-effectiveness of COVID rapid diagnostic tests for patients with severe/critical illness in low- and middle-income countries: A modeling study

10. Improving the contribution of mathematical modelling evidence to guidelines and policy: Experiences from tuberculosis

11. Cost-effectiveness of COVID rapid diagnostic tests for patients with severe/critical illness in low- and middle-income countries: A modeling study.

12. Effectiveness and cost-effectiveness of a transdiagnostic intervention for alcohol misuse and psychological distress in humanitarian settings: study protocol for a randomised controlled trial in Uganda

13. The costs of HIV prevention for different target populations in Mumbai, Thane and Banglalore

14. 'We usually see a lot of delay in terms of coming for or seeking care': an expert consultation on COVID testing and care pathways in seven low- and middle-income countries

15. The use of cost-effectiveness analysis for health benefit package design – should countries follow a sectoral, incremental or hybrid approach?

18. 'Going into the black box': a policy analysis of how the World Health Organization uses evidence to inform guideline recommendations

19. Costs incurred by people with co-morbid tuberculosis and diabetes and their households in the Philippines.

20. Uncertainty in tuberculosis clinical decision-making: An umbrella review with systematic methods and thematic analysis.

21. Catastrophic costs for tuberculosis patients in India: Impact of methodological choices.

26. Assessing the impacts of COVID-19 vaccination programme’s timing and speed on health benefits, cost-effectiveness, and relative affordability in 27 African countries

29. Study protocol for the Integra Initiative to assess the benefits and costs of integrating sexual and reproductive health and HIV services in Kenya and Swaziland

30. Factors influencing institutionalization of health technology assessment in Kenya

31. Transcriptional Alterations Induced by Delta-9 Tetrahydrocannabinol in the Brain and Gonads of Adult Medaka

32. Superspreading, overdispersion and their implications in the SARS-CoV-2 (COVID-19) pandemic: a systematic review and meta-analysis of the literature

33. What are economic costs and when should they be used in health economic studies?

34. COVID-19 vaccine hesitancy and social contact patterns in Pakistan: results from a national cross-sectional survey

36. Scientific advances and the end of tuberculosis: a report from the Lancet Commission on Tuberculosis

38. Moving away from the unit cost. Predicting country-specific average cost curves of VMMC services accounting for variations in service delivery platforms in sub-Saharan Africa.

39. Correction: Effectiveness and cost-effectiveness of a transdiagnostic intervention for alcohol misuse and psychological distress in humanitarian settings: study protocol for a randomised controlled trial in Uganda

40. Factors Influencing the Institutionalization of Health Technology Assessment: A Scoping Literature Review

41. International Partnerships to Develop Evidence-informed Priority Setting Institutions: Ten Years of Experience from the International Decision Support Initiative (iDSI)

43. Assessing the impacts of COVID-19 vaccination programme’s timing and speed on health benefits, cost-effectiveness, and relative affordability in 27 African countries

46. Costs of treating childhood malaria, diarrhoea and pneumonia in rural Mozambique and Uganda

47. Considering equity in priority setting using transmission models: Recommendations and data needs

48. Improving outcomes for children with malaria, diarrhoea and pneumonia in Mozambique: A cluster randomised controlled trial of the inSCALE technology innovation.

49. Improving community health worker treatment for malaria, diarrhoea, and pneumonia in Uganda through inSCALE community and mHealth innovations: A cluster randomised controlled trial.

50. Estimating the health and macroeconomic burdens of tuberculosis in India, 2021–2040: A fully integrated modelling study.